Laoruangroj C, Atherton PJ, Wiseman GA, Ansell S, et al. The asymptomatic follicular lymphoma (AFL) trial: single-agent rituximab immunotherapy versus 90Y-ibritumomab tiuxetan radioimmunotherapy (RIT) for patients with new, untreated follicular lymphoma. Leuk Lymphoma 2024 Jan 8:1-6. doi: 10.1080/10428194.2023.2295792.
PMID: 38189774